

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.63095805 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.63095805 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.46117791 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.46117791 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.75945007 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.53891881 |
| 7 | protein retention in ER lumen (GO:0006621) | 4.39547353 |
| 8 | barbed-end actin filament capping (GO:0051016) | 3.85355306 |
| 9 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.73019374 |
| 10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.69820660 |
| 11 | valine metabolic process (GO:0006573) | 3.64130229 |
| 12 | positive regulation of nuclease activity (GO:0032075) | 3.63150601 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.50077782 |
| 14 | protein localization to endosome (GO:0036010) | 3.34486999 |
| 15 | pentose-phosphate shunt (GO:0006098) | 3.31934748 |
| 16 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.30458633 |
| 17 | regulation of nuclease activity (GO:0032069) | 3.26173815 |
| 18 | peptide catabolic process (GO:0043171) | 3.19701284 |
| 19 | cellular response to unfolded protein (GO:0034620) | 3.16845919 |
| 20 | COPII vesicle coating (GO:0048208) | 3.15827404 |
| 21 | mannose metabolic process (GO:0006013) | 3.13822596 |
| 22 | adhesion of symbiont to host (GO:0044406) | 3.13781626 |
| 23 | virion attachment to host cell (GO:0019062) | 3.11915121 |
| 24 | adhesion of symbiont to host cell (GO:0044650) | 3.11915121 |
| 25 | signal peptide processing (GO:0006465) | 3.11367062 |
| 26 | regulation of extracellular matrix disassembly (GO:0010715) | 3.11338527 |
| 27 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.09475353 |
| 28 | protein carboxylation (GO:0018214) | 3.05637084 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.05637084 |
| 30 | basement membrane organization (GO:0071711) | 3.03597331 |
| 31 | 4-hydroxyproline metabolic process (GO:0019471) | 3.02081076 |
| 32 | apoptotic cell clearance (GO:0043277) | 3.01393080 |
| 33 | ER-nucleus signaling pathway (GO:0006984) | 3.01160641 |
| 34 | regulation of early endosome to late endosome transport (GO:2000641) | 3.00940270 |
| 35 | pinocytosis (GO:0006907) | 2.99631256 |
| 36 | NADPH regeneration (GO:0006740) | 2.98681024 |
| 37 | sequestering of metal ion (GO:0051238) | 2.97717572 |
| 38 | cellular response to topologically incorrect protein (GO:0035967) | 2.96666036 |
| 39 | stress fiber assembly (GO:0043149) | 2.95767627 |
| 40 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.95759018 |
| 41 | positive regulation of histone deacetylation (GO:0031065) | 2.88901721 |
| 42 | sulfur amino acid catabolic process (GO:0000098) | 2.88832401 |
| 43 | glycosphingolipid catabolic process (GO:0046479) | 2.86199792 |
| 44 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.83765686 |
| 45 | tricarboxylic acid metabolic process (GO:0072350) | 2.80898831 |
| 46 | alpha-linolenic acid metabolic process (GO:0036109) | 2.74261663 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 2.72854120 |
| 48 | complement activation, alternative pathway (GO:0006957) | 2.71698740 |
| 49 | positive regulation of receptor recycling (GO:0001921) | 2.70727945 |
| 50 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.65582114 |
| 51 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.65582114 |
| 52 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.63741158 |
| 53 | angiotensin maturation (GO:0002003) | 2.63045727 |
| 54 | response to endoplasmic reticulum stress (GO:0034976) | 2.61478163 |
| 55 | fibril organization (GO:0097435) | 2.61050328 |
| 56 | hyaluronan catabolic process (GO:0030214) | 2.60419119 |
| 57 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.60283470 |
| 58 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.60029161 |
| 59 | glycolipid catabolic process (GO:0019377) | 2.56717521 |
| 60 | response to laminar fluid shear stress (GO:0034616) | 2.56340242 |
| 61 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.56185258 |
| 62 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.55336964 |
| 63 | glucose catabolic process (GO:0006007) | 2.54670371 |
| 64 | exocrine pancreas development (GO:0031017) | 2.53348943 |
| 65 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.50795206 |
| 66 | maternal placenta development (GO:0001893) | 2.50748420 |
| 67 | response to thyroid hormone (GO:0097066) | 2.49593006 |
| 68 | low-density lipoprotein particle clearance (GO:0034383) | 2.47020548 |
| 69 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.44836789 |
| 70 | intestinal cholesterol absorption (GO:0030299) | 2.44711305 |
| 71 | keratan sulfate catabolic process (GO:0042340) | 2.43718689 |
| 72 | extracellular fibril organization (GO:0043206) | 2.43520475 |
| 73 | L-phenylalanine metabolic process (GO:0006558) | 2.43446689 |
| 74 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.43446689 |
| 75 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.43417295 |
| 76 | peptidyl-asparagine modification (GO:0018196) | 2.42251885 |
| 77 | lysine metabolic process (GO:0006553) | 2.40885929 |
| 78 | lysine catabolic process (GO:0006554) | 2.40885929 |
| 79 | 2-oxoglutarate metabolic process (GO:0006103) | 2.40178989 |
| 80 | negative regulation of fibrinolysis (GO:0051918) | 2.39666686 |
| 81 | skin morphogenesis (GO:0043589) | 2.39407826 |
| 82 | regulation of complement activation (GO:0030449) | 2.39130976 |
| 83 | modulation by symbiont of host cellular process (GO:0044068) | 2.38818866 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.38338732 |
| 85 | regulation of protein activation cascade (GO:2000257) | 2.37300155 |
| 86 | protein autoprocessing (GO:0016540) | 2.37072080 |
| 87 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.36187053 |
| 88 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.35999983 |
| 89 | hormone catabolic process (GO:0042447) | 2.35960018 |
| 90 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.35837868 |
| 91 | positive regulation of protein deacetylation (GO:0090312) | 2.35524436 |
| 92 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.34906614 |
| 93 | transcytosis (GO:0045056) | 2.34373695 |
| 94 | definitive hemopoiesis (GO:0060216) | 2.34196543 |
| 95 | amino sugar catabolic process (GO:0046348) | 2.34072783 |
| 96 | cysteine metabolic process (GO:0006534) | 2.33284960 |
| 97 | oxaloacetate metabolic process (GO:0006107) | 2.32998336 |
| 98 | vesicle coating (GO:0006901) | 2.32723919 |
| 99 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.32391584 |
| 100 | L-phenylalanine catabolic process (GO:0006559) | 2.32391584 |
| 101 | regulation of extracellular matrix organization (GO:1903053) | 2.32109396 |
| 102 | glucose 6-phosphate metabolic process (GO:0051156) | 2.32039322 |
| 103 | response to unfolded protein (GO:0006986) | 2.31485688 |
| 104 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.30236180 |
| 105 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.29137506 |
| 106 | positive regulation of extracellular matrix organization (GO:1903055) | 2.28972376 |
| 107 | NADH metabolic process (GO:0006734) | 2.28265750 |
| 108 | regulation of cholesterol storage (GO:0010885) | 2.28240622 |
| 109 | negative regulation of phagocytosis (GO:0050765) | 2.27749468 |
| 110 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.27392226 |
| 111 | regulation of apoptotic cell clearance (GO:2000425) | 2.26447273 |
| 112 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.25871011 |
| 113 | defense response to fungus (GO:0050832) | 2.24951796 |
| 114 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.24168686 |
| 115 | detection of bacterium (GO:0016045) | 2.24041961 |
| 116 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.23835638 |
| 117 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.23468756 |
| 118 | detection of other organism (GO:0098543) | 2.22838684 |
| 119 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.22763397 |
| 120 | negative regulation of cell killing (GO:0031342) | 2.22002151 |
| 121 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.22002151 |
| 122 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.21353733 |
| 123 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.21300060 |
| 124 | activation of MAPKKK activity (GO:0000185) | 2.21041178 |
| 125 | protein N-linked glycosylation (GO:0006487) | 2.21006388 |
| 126 | response to topologically incorrect protein (GO:0035966) | 2.20978005 |
| 127 | response to peptidoglycan (GO:0032494) | 2.20808522 |
| 128 | endodermal cell differentiation (GO:0035987) | 2.20778305 |
| 129 | toxin transport (GO:1901998) | 2.20531596 |
| 130 | regulation of leukocyte degranulation (GO:0043300) | 2.19997999 |
| 131 | growth hormone receptor signaling pathway (GO:0060396) | 2.19123914 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.17648487 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.17648487 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 2.17648487 |
| 135 | positive regulation by symbiont of host defense response (GO:0052509) | 2.17648487 |
| 136 | modulation by symbiont of host defense response (GO:0052031) | 2.17648487 |
| 137 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.17648487 |
| 138 | cortical actin cytoskeleton organization (GO:0030866) | 2.17127050 |
| 139 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.17108344 |
| 140 | regulation of plasminogen activation (GO:0010755) | 2.16589900 |
| 141 | drug transmembrane transport (GO:0006855) | 2.16429675 |
| 142 | ethanol oxidation (GO:0006069) | 2.16332744 |
| 143 | negative regulation of fatty acid transport (GO:2000192) | 2.16051247 |
| 144 | regulation of macrophage chemotaxis (GO:0010758) | 2.15814440 |
| 145 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.15805854 |
| 146 | high-density lipoprotein particle remodeling (GO:0034375) | 2.15703776 |
| 147 | positive regulation of cholesterol efflux (GO:0010875) | 2.15288800 |
| 148 | negative regulation of lipid transport (GO:0032369) | 2.15164651 |
| 149 | fatty acid beta-oxidation (GO:0006635) | 2.15036339 |
| 150 | hexose catabolic process (GO:0019320) | 2.14891867 |
| 151 | detection of external biotic stimulus (GO:0098581) | 2.14212729 |
| 152 | positive regulation of phagocytosis (GO:0050766) | 2.13765574 |
| 153 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.13612985 |
| 154 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.13362977 |
| 155 | endothelial cell chemotaxis (GO:0035767) | 2.13353518 |
| 156 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.12573643 |
| 157 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.12063043 |
| 158 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.12042501 |
| 159 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.11950882 |
| 160 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.11947736 |
| 161 | surfactant homeostasis (GO:0043129) | 2.11801961 |
| 162 | regulation of erythrocyte differentiation (GO:0045646) | 2.11639497 |
| 163 | venous blood vessel morphogenesis (GO:0048845) | 2.11127728 |
| 164 | cell-substrate junction assembly (GO:0007044) | 2.10768757 |
| 165 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.10560266 |
| 166 | adherens junction assembly (GO:0034333) | 2.09910409 |
| 167 | epithelial cell-cell adhesion (GO:0090136) | 2.09756089 |
| 168 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.09685720 |
| 169 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.09596388 |
| 170 | ceramide catabolic process (GO:0046514) | 2.06968469 |
| 171 | embryo implantation (GO:0007566) | 2.06886655 |
| 172 | oligosaccharide catabolic process (GO:0009313) | 2.05686356 |
| 173 | detection of molecule of bacterial origin (GO:0032490) | 2.04578147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.36035980 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.50390120 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18687252 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.03892594 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 2.70941722 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.66987633 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.46828795 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37163561 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.30295553 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29546744 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.23522943 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23065622 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.20083540 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19793748 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.17604357 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15073938 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13544524 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.07615449 |
| 19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.05420291 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.03095139 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86978630 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85850650 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81113094 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78626956 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78048453 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76760733 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74307053 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71272238 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70940635 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66017323 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66007959 |
| 32 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63897005 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61669034 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60913370 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.60210680 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.59967966 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.58629969 |
| 38 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.56282731 |
| 39 | * MAF_26560356_Chip-Seq_TH1_Human | 1.55002247 |
| 40 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54058862 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51041316 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.50063339 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47844083 |
| 44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.46254988 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46157294 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44860173 |
| 47 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43260538 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43148003 |
| 49 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.42614461 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42174231 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40263589 |
| 52 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39989021 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39556995 |
| 54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39154883 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38596550 |
| 56 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38195662 |
| 57 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37719089 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.37648760 |
| 59 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35387002 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35228309 |
| 61 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35059698 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35021731 |
| 63 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34852204 |
| 64 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34068296 |
| 65 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34046167 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33885230 |
| 67 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.32635983 |
| 68 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32263231 |
| 69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31665422 |
| 70 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29665405 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29636181 |
| 72 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29406407 |
| 73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.29330851 |
| 74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29020914 |
| 75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.28764629 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27314799 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27312733 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26186462 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25302495 |
| 80 | P68_20966046_ChIP-Seq_HELA_Human | 1.24250210 |
| 81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.24036556 |
| 82 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23547227 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23452216 |
| 84 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23203948 |
| 85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22721376 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.22496154 |
| 87 | MYB_26560356_Chip-Seq_TH2_Human | 1.22398241 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21684597 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.21271128 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20070353 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19900958 |
| 92 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.19756197 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19652473 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19207148 |
| 95 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19164121 |
| 96 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18816518 |
| 97 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.18406776 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18330941 |
| 99 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17954911 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17596038 |
| 101 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17389770 |
| 102 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16649553 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16596141 |
| 104 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14825130 |
| 105 | SPI1_23127762_ChIP-Seq_K562_Human | 1.14742604 |
| 106 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.14553666 |
| 107 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14399340 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14364183 |
| 109 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14004596 |
| 110 | * MYB_26560356_Chip-Seq_TH1_Human | 1.12926493 |
| 111 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09568082 |
| 112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09089927 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09089927 |
| 114 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09047368 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08754658 |
| 116 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08597128 |
| 117 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.08575809 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08401209 |
| 119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08235025 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 1.07225509 |
| 121 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06400733 |
| 122 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05158694 |
| 123 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04239373 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03826139 |
| 125 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02414705 |
| 126 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.01752830 |
| 127 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01166409 |
| 128 | MAF_26560356_Chip-Seq_TH2_Human | 1.01002795 |
| 129 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00805300 |
| 130 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00174043 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98228753 |
| 132 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.98058701 |
| 133 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97599743 |
| 134 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95504983 |
| 135 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95027728 |
| 136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93887379 |
| 137 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93336255 |
| 138 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93302038 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 2.94724977 |
| 2 | MP0003300_gastrointestinal_ulcer | 2.93835614 |
| 3 | MP0006054_spinal_hemorrhage | 2.87924683 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 2.65148875 |
| 5 | MP0005360_urolithiasis | 2.44857127 |
| 6 | MP0005451_abnormal_body_composition | 2.40466105 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.33504462 |
| 8 | MP0005365_abnormal_bile_salt | 2.31917323 |
| 9 | MP0009840_abnormal_foam_cell | 2.24775971 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.13742343 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.12471505 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 1.88847464 |
| 13 | MP0004858_abnormal_nervous_system | 1.78433237 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 1.78057945 |
| 15 | MP0003252_abnormal_bile_duct | 1.77760873 |
| 16 | MP0004510_myositis | 1.77154181 |
| 17 | MP0003566_abnormal_cell_adhesion | 1.75439250 |
| 18 | MP0003329_amyloid_beta_deposits | 1.75226954 |
| 19 | MP0005464_abnormal_platelet_physiology | 1.72677538 |
| 20 | MP0005257_abnormal_intraocular_pressure | 1.72284117 |
| 21 | MP0000604_amyloidosis | 1.71639484 |
| 22 | MP0008260_abnormal_autophagy | 1.71487431 |
| 23 | MP0001849_ear_inflammation | 1.65376109 |
| 24 | MP0003724_increased_susceptibility_to | 1.64159078 |
| 25 | MP0003091_abnormal_cell_migration | 1.63668380 |
| 26 | MP0003303_peritoneal_inflammation | 1.62747314 |
| 27 | MP0003075_altered_response_to | 1.62385440 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.61411929 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.60606073 |
| 30 | MP0003436_decreased_susceptibility_to | 1.57867088 |
| 31 | MP0005275_abnormal_skin_tensile | 1.57420579 |
| 32 | MP0005083_abnormal_biliary_tract | 1.54473262 |
| 33 | MP0002998_abnormal_bone_remodeling | 1.54213523 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.54052243 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.53900787 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.53851821 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.53701730 |
| 38 | MP0005220_abnormal_exocrine_pancreas | 1.52409835 |
| 39 | MP0008875_abnormal_xenobiotic_pharmacok | 1.51545629 |
| 40 | MP0000751_myopathy | 1.45635023 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.40752481 |
| 42 | MP0000685_abnormal_immune_system | 1.38195960 |
| 43 | MP0003453_abnormal_keratinocyte_physiol | 1.36764286 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.35528783 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.33109753 |
| 46 | MP0003279_aneurysm | 1.32590091 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.32260658 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.31043109 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.31043109 |
| 50 | MP0005023_abnormal_wound_healing | 1.30862064 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.30605610 |
| 52 | MP0001958_emphysema | 1.28996532 |
| 53 | MP0000609_abnormal_liver_physiology | 1.28795499 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.27585907 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.26383698 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.24659094 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 1.22695961 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.22562291 |
| 59 | MP0004947_skin_inflammation | 1.20184005 |
| 60 | MP0002148_abnormal_hypersensitivity_rea | 1.19175935 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.18004676 |
| 62 | MP0004272_abnormal_basement_membrane | 1.17335804 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.14246583 |
| 64 | MP0001542_abnormal_bone_strength | 1.13110582 |
| 65 | MP0002419_abnormal_innate_immunity | 1.13085116 |
| 66 | MP0003828_pulmonary_edema | 1.11792584 |
| 67 | MP0009278_abnormal_bone_marrow | 1.11182936 |
| 68 | MP0003195_calcinosis | 1.11018437 |
| 69 | MP0003690_abnormal_glial_cell | 1.10642551 |
| 70 | MP0001873_stomach_inflammation | 1.10565659 |
| 71 | MP0005025_abnormal_response_to | 1.10393424 |
| 72 | MP0005165_increased_susceptibility_to | 1.10146838 |
| 73 | MP0008469_abnormal_protein_level | 1.08786507 |
| 74 | MP0005409_darkened_coat_color | 1.08199735 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.07844469 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.06703184 |
| 77 | MP0002060_abnormal_skin_morphology | 1.06672320 |
| 78 | MP0003448_altered_tumor_morphology | 1.06456652 |
| 79 | MP0005166_decreased_susceptibility_to | 1.05347260 |
| 80 | MP0005076_abnormal_cell_differentiation | 1.05324213 |
| 81 | MP0000678_abnormal_parathyroid_gland | 1.05166529 |
| 82 | MP0008004_abnormal_stomach_pH | 1.04800122 |
| 83 | MP0000343_altered_response_to | 1.04580935 |
| 84 | MP0002254_reproductive_system_inflammat | 1.03731816 |
| 85 | MP0005666_abnormal_adipose_tissue | 1.03209071 |
| 86 | MP0005332_abnormal_amino_acid | 1.02681180 |
| 87 | MP0001756_abnormal_urination | 1.01764396 |
| 88 | MP0000598_abnormal_liver_morphology | 1.01522859 |
| 89 | MP0003866_abnormal_defecation | 1.00417565 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.99816008 |
| 91 | MP0000858_altered_metastatic_potential | 0.99329880 |
| 92 | MP0001944_abnormal_pancreas_morphology | 0.97413698 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.97033039 |
| 94 | MP0005164_abnormal_response_to | 0.96931655 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.96515687 |
| 96 | MP0002933_joint_inflammation | 0.96191118 |
| 97 | MP0002118_abnormal_lipid_homeostasis | 0.95765857 |
| 98 | MP0000490_abnormal_crypts_of | 0.93000528 |
| 99 | MP0009785_altered_susceptibility_to | 0.92455522 |
| 100 | MP0005503_abnormal_tendon_morphology | 0.91869344 |
| 101 | MP0000249_abnormal_blood_vessel | 0.89994957 |
| 102 | MP0000747_muscle_weakness | 0.89621184 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.89466431 |
| 104 | MP0001879_abnormal_lymphatic_vessel | 0.89324266 |
| 105 | MP0001790_abnormal_immune_system | 0.88728394 |
| 106 | MP0005387_immune_system_phenotype | 0.88728394 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.88229113 |
| 108 | MP0003806_abnormal_nucleotide_metabolis | 0.87436308 |
| 109 | MP0003868_abnormal_feces_composition | 0.85991359 |
| 110 | MP0009333_abnormal_splenocyte_physiolog | 0.85415004 |
| 111 | MP0006082_CNS_inflammation | 0.83119575 |
| 112 | MP0003186_abnormal_redox_activity | 0.82785986 |
| 113 | MP0003795_abnormal_bone_structure | 0.82758900 |
| 114 | MP0000003_abnormal_adipose_tissue | 0.81855906 |
| 115 | MP0001851_eye_inflammation | 0.81623244 |
| 116 | MP0000920_abnormal_myelination | 0.81556249 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.81245728 |
| 118 | MP0002405_respiratory_system_inflammati | 0.81100970 |
| 119 | MP0001915_intracranial_hemorrhage | 0.80981406 |
| 120 | MP0005000_abnormal_immune_tolerance | 0.80940199 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.80886567 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.80516962 |
| 123 | MP0005670_abnormal_white_adipose | 0.80266209 |
| 124 | MP0005595_abnormal_vascular_smooth | 0.79936769 |
| 125 | MP0002909_abnormal_adrenal_gland | 0.79659501 |
| 126 | MP0002723_abnormal_immune_serum | 0.79633437 |
| 127 | MP0002452_abnormal_antigen_presenting | 0.78905749 |
| 128 | MP0002135_abnormal_kidney_morphology | 0.78781695 |
| 129 | MP0004130_abnormal_muscle_cell | 0.78280088 |
| 130 | MP0005390_skeleton_phenotype | 0.77947499 |
| 131 | MP0009764_decreased_sensitivity_to | 0.77809486 |
| 132 | MP0002928_abnormal_bile_duct | 0.77757967 |
| 133 | MP0002971_abnormal_brown_adipose | 0.77630736 |
| 134 | MP0005375_adipose_tissue_phenotype | 0.77021232 |
| 135 | MP0002693_abnormal_pancreas_physiology | 0.75940203 |
| 136 | MP0009763_increased_sensitivity_to | 0.75745881 |
| 137 | MP0000767_abnormal_smooth_muscle | 0.75742430 |
| 138 | MP0005508_abnormal_skeleton_morphology | 0.75212151 |
| 139 | MP0002089_abnormal_postnatal_growth/wei | 0.75187422 |
| 140 | MP0001819_abnormal_immune_cell | 0.73580170 |
| 141 | MP0002420_abnormal_adaptive_immunity | 0.73221973 |
| 142 | MP0006138_congestive_heart_failure | 0.72614654 |
| 143 | MP0003634_abnormal_glial_cell | 0.72096603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 3.80851930 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.80851930 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.80851930 |
| 4 | Protrusio acetabuli (HP:0003179) | 3.55519059 |
| 5 | Dysostosis multiplex (HP:0000943) | 3.49069396 |
| 6 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.43816540 |
| 7 | Mucopolysacchariduria (HP:0008155) | 3.43816540 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 3.20090294 |
| 9 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.10937734 |
| 10 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.10937734 |
| 11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.10937734 |
| 12 | Petechiae (HP:0000967) | 2.96910262 |
| 13 | Abnormal platelet function (HP:0011869) | 2.93489177 |
| 14 | Impaired platelet aggregation (HP:0003540) | 2.93489177 |
| 15 | Deep venous thrombosis (HP:0002625) | 2.91850651 |
| 16 | Hypoglycemic coma (HP:0001325) | 2.89847883 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 2.89106839 |
| 18 | Cervical subluxation (HP:0003308) | 2.87516176 |
| 19 | Cerebral aneurysm (HP:0004944) | 2.80590852 |
| 20 | Increased connective tissue (HP:0009025) | 2.76736931 |
| 21 | Aortic aneurysm (HP:0004942) | 2.74146086 |
| 22 | Premature rupture of membranes (HP:0001788) | 2.72536732 |
| 23 | Thrombocytosis (HP:0001894) | 2.72126047 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70618235 |
| 25 | Increased variability in muscle fiber diameter (HP:0003557) | 2.59717008 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 2.57341754 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.57065812 |
| 28 | Complement deficiency (HP:0004431) | 2.56896590 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 2.53375036 |
| 30 | Menorrhagia (HP:0000132) | 2.51156170 |
| 31 | Beaking of vertebral bodies (HP:0004568) | 2.50989219 |
| 32 | Xanthomatosis (HP:0000991) | 2.50412888 |
| 33 | Peritonitis (HP:0002586) | 2.49396554 |
| 34 | Distal lower limb muscle weakness (HP:0009053) | 2.47406484 |
| 35 | Aortic dissection (HP:0002647) | 2.46113388 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.44823793 |
| 37 | Neurofibrillary tangles (HP:0002185) | 2.43827765 |
| 38 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.43571448 |
| 39 | Axonal loss (HP:0003447) | 2.42815170 |
| 40 | Loss of speech (HP:0002371) | 2.41956631 |
| 41 | Nonimmune hydrops fetalis (HP:0001790) | 2.41728103 |
| 42 | Interstitial pulmonary disease (HP:0006530) | 2.40330989 |
| 43 | Late onset (HP:0003584) | 2.38266117 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.35957261 |
| 45 | Nuclear cataract (HP:0100018) | 2.35807621 |
| 46 | Polycythemia (HP:0001901) | 2.32785660 |
| 47 | Achilles tendon contracture (HP:0001771) | 2.31375063 |
| 48 | Amyloidosis (HP:0011034) | 2.31242791 |
| 49 | Abnormality of complement system (HP:0005339) | 2.27851150 |
| 50 | Abnormality of the Achilles tendon (HP:0005109) | 2.27664986 |
| 51 | Hemorrhage of the eye (HP:0011885) | 2.26964804 |
| 52 | Epistaxis (HP:0000421) | 2.26629586 |
| 53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.26086337 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.22512421 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.22426487 |
| 56 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.22116567 |
| 57 | Intrahepatic cholestasis (HP:0001406) | 2.21407303 |
| 58 | Chronic otitis media (HP:0000389) | 2.20922248 |
| 59 | Spinal rigidity (HP:0003306) | 2.19908234 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.19701903 |
| 61 | Nasal polyposis (HP:0100582) | 2.18665952 |
| 62 | Aneurysm (HP:0002617) | 2.16693269 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.15849898 |
| 64 | Upper limb amyotrophy (HP:0009129) | 2.15340314 |
| 65 | Distal upper limb amyotrophy (HP:0007149) | 2.15340314 |
| 66 | Ankle contracture (HP:0006466) | 2.15157080 |
| 67 | Cerebral inclusion bodies (HP:0100314) | 2.14107403 |
| 68 | Abnormal platelet volume (HP:0011876) | 2.12602171 |
| 69 | Ketoacidosis (HP:0001993) | 2.11126183 |
| 70 | Wormian bones (HP:0002645) | 2.10118965 |
| 71 | Purpura (HP:0000979) | 2.09623159 |
| 72 | J-shaped sella turcica (HP:0002680) | 2.08842995 |
| 73 | Vascular tortuosity (HP:0004948) | 2.08537615 |
| 74 | Increased mean platelet volume (HP:0011877) | 2.08314925 |
| 75 | Gingival bleeding (HP:0000225) | 2.07086014 |
| 76 | Eczematoid dermatitis (HP:0000976) | 2.06715598 |
| 77 | Ketosis (HP:0001946) | 2.05951861 |
| 78 | Thoracic kyphosis (HP:0002942) | 2.05028770 |
| 79 | Type 1 muscle fiber predominance (HP:0003803) | 2.04086450 |
| 80 | Spondylolisthesis (HP:0003302) | 2.01106803 |
| 81 | Joint stiffness (HP:0001387) | 2.01073338 |
| 82 | Glomerulonephritis (HP:0000099) | 1.99641788 |
| 83 | Hypoglycemic seizures (HP:0002173) | 1.99094663 |
| 84 | Bladder diverticulum (HP:0000015) | 1.97197658 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 1.96258769 |
| 86 | Abnormal gallbladder physiology (HP:0012438) | 1.94212225 |
| 87 | Cholecystitis (HP:0001082) | 1.94212225 |
| 88 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93622498 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93156782 |
| 90 | Myocardial infarction (HP:0001658) | 1.93117222 |
| 91 | Joint hemorrhage (HP:0005261) | 1.92875198 |
| 92 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92399731 |
| 93 | Atrophic scars (HP:0001075) | 1.91384684 |
| 94 | Broad metatarsal (HP:0001783) | 1.90977888 |
| 95 | Hyperbilirubinemia (HP:0002904) | 1.90790804 |
| 96 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.90622948 |
| 97 | Malnutrition (HP:0004395) | 1.90526320 |
| 98 | Arterial tortuosity (HP:0005116) | 1.89033953 |
| 99 | Hematochezia (HP:0002573) | 1.88672733 |
| 100 | Emphysema (HP:0002097) | 1.88214734 |
| 101 | Fragile skin (HP:0001030) | 1.87377568 |
| 102 | Abnormality of the lumbar spine (HP:0100712) | 1.87231006 |
| 103 | Shallow orbits (HP:0000586) | 1.87019102 |
| 104 | Ectopia lentis (HP:0001083) | 1.86334728 |
| 105 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.85965559 |
| 106 | Abnormality of the thoracic spine (HP:0100711) | 1.85820341 |
| 107 | Generalized aminoaciduria (HP:0002909) | 1.85714854 |
| 108 | Ovoid vertebral bodies (HP:0003300) | 1.85173430 |
| 109 | Abdominal distention (HP:0003270) | 1.84949373 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.84607854 |
| 111 | Cellulitis (HP:0100658) | 1.84263423 |
| 112 | Hypertriglyceridemia (HP:0002155) | 1.83657155 |
| 113 | Polygenic inheritance (HP:0010982) | 1.82773922 |
| 114 | Cardiomegaly (HP:0001640) | 1.81814043 |
| 115 | Hyperacusis (HP:0010780) | 1.81766680 |
| 116 | Thin bony cortex (HP:0002753) | 1.80487246 |
| 117 | Mitral stenosis (HP:0001718) | 1.79584807 |
| 118 | Mesangial abnormality (HP:0001966) | 1.79489800 |
| 119 | Genu recurvatum (HP:0002816) | 1.78777300 |
| 120 | Abnormality of the acetabulum (HP:0003170) | 1.77590770 |
| 121 | Severe short stature (HP:0003510) | 1.77107201 |
| 122 | Insulin resistance (HP:0000855) | 1.76854868 |
| 123 | Obstructive sleep apnea (HP:0002870) | 1.75677864 |
| 124 | Mitral valve prolapse (HP:0001634) | 1.75543910 |
| 125 | Gingivitis (HP:0000230) | 1.74603258 |
| 126 | Thoracolumbar scoliosis (HP:0002944) | 1.73493976 |
| 127 | Esophageal varix (HP:0002040) | 1.73024726 |
| 128 | Mitral regurgitation (HP:0001653) | 1.72539764 |
| 129 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.72220347 |
| 130 | Recurrent abscess formation (HP:0002722) | 1.71214880 |
| 131 | Slender build (HP:0001533) | 1.70988049 |
| 132 | Disproportionate tall stature (HP:0001519) | 1.70883825 |
| 133 | Radial bowing (HP:0002986) | 1.70557814 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70262881 |
| 135 | Osteolytic defects of the hand bones (HP:0009699) | 1.70262881 |
| 136 | Nephritis (HP:0000123) | 1.69756839 |
| 137 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69212362 |
| 138 | Hand muscle atrophy (HP:0009130) | 1.68816541 |
| 139 | Long toe (HP:0010511) | 1.68399706 |
| 140 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67136337 |
| 141 | Bone pain (HP:0002653) | 1.66963762 |
| 142 | Prolonged partial thromboplastin time (HP:0003645) | 1.66202752 |
| 143 | Broad face (HP:0000283) | 1.66154817 |
| 144 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.65767883 |
| 145 | Pathologic fracture (HP:0002756) | 1.64079091 |
| 146 | Biconcave vertebral bodies (HP:0004586) | 1.63973196 |
| 147 | Generalized amyotrophy (HP:0003700) | 1.62615567 |
| 148 | Protuberant abdomen (HP:0001538) | 1.62155864 |
| 149 | Increased serum ferritin (HP:0003281) | 1.61965695 |
| 150 | Blue sclerae (HP:0000592) | 1.61718466 |
| 151 | Dilatation of the ascending aorta (HP:0005111) | 1.61356906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.16784339 |
| 2 | TRIB3 | 4.10895070 |
| 3 | PKN2 | 3.17797786 |
| 4 | TAOK3 | 3.09559203 |
| 5 | PRPF4B | 3.00568483 |
| 6 | EEF2K | 2.81437153 |
| 7 | FLT3 | 2.13103505 |
| 8 | TGFBR2 | 2.09885019 |
| 9 | BCKDK | 2.06410527 |
| 10 | TAOK2 | 2.00564078 |
| 11 | SMG1 | 2.00478927 |
| 12 | PTK6 | 1.95643323 |
| 13 | SIK1 | 1.95148336 |
| 14 | ICK | 1.87012374 |
| 15 | LRRK2 | 1.84050362 |
| 16 | KDR | 1.74833300 |
| 17 | MAP4K1 | 1.72564454 |
| 18 | SCYL2 | 1.66231002 |
| 19 | MAP2K3 | 1.65572461 |
| 20 | MAPKAPK3 | 1.60737922 |
| 21 | RIPK4 | 1.56300197 |
| 22 | TBK1 | 1.53934782 |
| 23 | KIT | 1.52395726 |
| 24 | RIPK1 | 1.50076516 |
| 25 | EPHB1 | 1.49961250 |
| 26 | MAP3K13 | 1.49334411 |
| 27 | FGFR4 | 1.49036181 |
| 28 | PIK3CG | 1.48031846 |
| 29 | TIE1 | 1.47725472 |
| 30 | MAP3K10 | 1.46469882 |
| 31 | ZAP70 | 1.46171880 |
| 32 | JAK3 | 1.45332008 |
| 33 | TTN | 1.45299335 |
| 34 | CDC42BPA | 1.40954417 |
| 35 | MAPK15 | 1.35485694 |
| 36 | ARAF | 1.35443425 |
| 37 | PAK4 | 1.33106758 |
| 38 | TYK2 | 1.32831167 |
| 39 | BTK | 1.30658794 |
| 40 | PIM2 | 1.27196591 |
| 41 | TGFBR1 | 1.23308773 |
| 42 | MYLK | 1.19121138 |
| 43 | STK10 | 1.18915909 |
| 44 | PRKD2 | 1.18075270 |
| 45 | BLK | 1.17204176 |
| 46 | IRAK3 | 1.15695533 |
| 47 | PDGFRA | 1.15625155 |
| 48 | KSR2 | 1.15137637 |
| 49 | MOS | 1.09433646 |
| 50 | NME2 | 1.05965678 |
| 51 | FRK | 1.02185254 |
| 52 | MAP3K3 | 1.00854115 |
| 53 | PDPK1 | 0.99755191 |
| 54 | TEC | 0.99661842 |
| 55 | MARK2 | 0.98654754 |
| 56 | EPHA3 | 0.96211587 |
| 57 | PASK | 0.95671746 |
| 58 | MST1R | 0.95408153 |
| 59 | MAP3K14 | 0.94553096 |
| 60 | JAK1 | 0.93542554 |
| 61 | NEK9 | 0.93267862 |
| 62 | NTRK1 | 0.93139881 |
| 63 | INSRR | 0.92465972 |
| 64 | MAP2K2 | 0.91526317 |
| 65 | MAP3K11 | 0.91341958 |
| 66 | PTK2 | 0.90767225 |
| 67 | PAK2 | 0.90043543 |
| 68 | EPHB2 | 0.88507604 |
| 69 | MAP3K6 | 0.87683996 |
| 70 | JAK2 | 0.86838489 |
| 71 | RPS6KA4 | 0.86017650 |
| 72 | HIPK2 | 0.84214094 |
| 73 | RPS6KB2 | 0.83344097 |
| 74 | LATS2 | 0.83226580 |
| 75 | CDK12 | 0.81408227 |
| 76 | TESK1 | 0.79528718 |
| 77 | MAP3K1 | 0.79480726 |
| 78 | PRKG2 | 0.78878522 |
| 79 | MATK | 0.71342995 |
| 80 | MAPK12 | 0.70197137 |
| 81 | TRPM7 | 0.67859644 |
| 82 | MAPK7 | 0.67595697 |
| 83 | FES | 0.67411614 |
| 84 | CSF1R | 0.65164090 |
| 85 | ABL2 | 0.64531378 |
| 86 | ILK | 0.64210852 |
| 87 | IKBKE | 0.63913564 |
| 88 | ITK | 0.63763148 |
| 89 | CAMK1D | 0.63279676 |
| 90 | CDK6 | 0.63237799 |
| 91 | CSK | 0.63168936 |
| 92 | MAP3K7 | 0.62586832 |
| 93 | DYRK1B | 0.62469592 |
| 94 | BMX | 0.61541380 |
| 95 | LIMK1 | 0.61067383 |
| 96 | IRAK4 | 0.60886361 |
| 97 | FGR | 0.59612063 |
| 98 | PDK1 | 0.57668075 |
| 99 | MAPK11 | 0.56432125 |
| 100 | MTOR | 0.54179698 |
| 101 | STK38 | 0.53629555 |
| 102 | RET | 0.53509818 |
| 103 | GRK6 | 0.53082469 |
| 104 | TAOK1 | 0.52290783 |
| 105 | MAP3K8 | 0.52032895 |
| 106 | RPS6KA2 | 0.51970599 |
| 107 | FGFR3 | 0.49208537 |
| 108 | RPS6KA6 | 0.48314684 |
| 109 | LMTK2 | 0.46788659 |
| 110 | PRKD1 | 0.45878603 |
| 111 | SYK | 0.45857932 |
| 112 | TNK2 | 0.44228336 |
| 113 | PIM1 | 0.44104192 |
| 114 | RPS6KL1 | 0.43890967 |
| 115 | RPS6KC1 | 0.43890967 |
| 116 | MAPK4 | 0.43734954 |
| 117 | EPHA2 | 0.43285994 |
| 118 | HCK | 0.43269012 |
| 119 | MAPKAPK2 | 0.43059918 |
| 120 | CHUK | 0.41959834 |
| 121 | LATS1 | 0.41902457 |
| 122 | IKBKB | 0.41880876 |
| 123 | MAP3K2 | 0.41481982 |
| 124 | LCK | 0.41226194 |
| 125 | BRSK2 | 0.41209155 |
| 126 | DAPK3 | 0.41034488 |
| 127 | DDR2 | 0.40865079 |
| 128 | PDGFRB | 0.40578898 |
| 129 | DMPK | 0.38460529 |
| 130 | STK3 | 0.38218737 |
| 131 | TESK2 | 0.38086077 |
| 132 | MET | 0.37377926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.49171224 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.49007741 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.26556271 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.26035447 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.23881383 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.15507461 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92032340 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.89004623 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.85279186 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80813026 |
| 11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.80230906 |
| 12 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.76712288 |
| 13 | Protein export_Homo sapiens_hsa03060 | 1.70722701 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.65052597 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64277177 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59460375 |
| 17 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.59046005 |
| 18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.58020806 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56354920 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48738020 |
| 21 | Sulfur relay system_Homo sapiens_hsa04122 | 1.47461947 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46236218 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.42595371 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.28597283 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27660134 |
| 26 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.26243588 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.25976576 |
| 28 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24914686 |
| 29 | Galactose metabolism_Homo sapiens_hsa00052 | 1.23132389 |
| 30 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.21717524 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20982838 |
| 32 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20216339 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.17185303 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15543902 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06921188 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.06878137 |
| 37 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03935455 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03752862 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00953366 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00507058 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.00033322 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99882901 |
| 43 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.99558244 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 0.97883227 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97840124 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.97000063 |
| 47 | Legionellosis_Homo sapiens_hsa05134 | 0.96981852 |
| 48 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96892671 |
| 49 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.96694750 |
| 50 | Insulin resistance_Homo sapiens_hsa04931 | 0.96031398 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 0.95155987 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.94404624 |
| 53 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93432814 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.93388710 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.93066475 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.91671579 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91552840 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.91204276 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90436361 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.88281728 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.87397879 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84678839 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83546429 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.83022014 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82924215 |
| 66 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82879333 |
| 67 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.82309323 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81495431 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.81099437 |
| 70 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80632639 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80506632 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80459041 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.80025345 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79922699 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79200881 |
| 76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.78202551 |
| 77 | Malaria_Homo sapiens_hsa05144 | 0.77847030 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77531139 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.76255127 |
| 80 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.75917194 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.75433900 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75349946 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75325538 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74305074 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74088530 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.74079179 |
| 87 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.73448611 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.73313950 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72652743 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72389732 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71679881 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.70786119 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69400466 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69143030 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68249913 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.68229294 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67252344 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.66449221 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.65006365 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64477854 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63773007 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63645365 |
| 103 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61540430 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.60994225 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60082234 |
| 106 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60012983 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.59166331 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58720153 |
| 109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58014724 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56120202 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55179784 |
| 112 | Measles_Homo sapiens_hsa05162 | 0.55174778 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54334656 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54077625 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53766124 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53731308 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53703562 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52963980 |
| 119 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52931082 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52810318 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52737071 |
| 122 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51415261 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51378950 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50840480 |
| 125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50610275 |
| 126 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.49880083 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49608966 |
| 128 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48216140 |
| 129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48042628 |
| 130 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47252842 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47146298 |
| 132 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.46768757 |
| 133 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46528102 |
| 134 | Glioma_Homo sapiens_hsa05214 | 0.46246013 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46244602 |
| 136 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46212140 |
| 137 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.45777993 |
| 138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45613718 |
| 139 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45271182 |
| 140 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45058400 |
| 141 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44917718 |
| 142 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43539246 |
| 143 | Tuberculosis_Homo sapiens_hsa05152 | 0.43237049 |
| 144 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43135849 |
| 145 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42921119 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.42852967 |
| 147 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42598807 |

